Obamacare failure may shave 30 percent from U.S. drug sales in 2017

... the report from Kleinrock's group, which is the research arm of IMS Health, a drug sales analysis company based in Danbury. Drug spending in 2012 was about $328 billion, the group said. Still, global spending on drugs is projected to surpass $1 ...



via Danbury Newswire http://www.newstimes.com/news/article/Obamacare-failure-may-shave-30-percent-from-U-S-4994714.php